Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost

CONCLUSION: This data allow clinicians to appropriately implement and inform patients of the therapeutic uses and clinical outcomes of stem cell boost in patients with multiply relapsed/refractory MM.PMID:38584546 | DOI:10.2174/011574888X287532240325041249

Source: Current Stem Cell Research and Therapy - April 8, 2024 Category: Stem Cells Authors: Ayrton Bangolo Samir Oza Ronit Slotky Aimee Chappell David Siegel Harsh Parmar Noa Biran David H Vesole Pooja Phull Source Type: research